Pelthos Therapeutics sells FDA approved prescription skin treatments for molluscum contagiosum and impetigo from its base in Durham, North Carolina. It last closed at $6.38 on Nov 20, down 8.73% on the day. The next earnings report for PTHS is expected around Thu, Mar 18, 2027. For the quarter ended Sep 2026, PTHS reported EPS of -$2.04 on revenue of $15.4M, with revenue up 107.9% from a year ago. Over its last 6 reports the stock moved an average of 5.7% the session after earnings. Over the last 12 months PTHS insiders bought $1000K of stock on the open market and sold $486K, according to SEC Form 4 filings.
AI Auto Pilots
Is PTHS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PTHS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PTHSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PTHS · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 57% below its 20 day and 159% below its 50 day average. It is 261% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the Pivot S1 at $6.10, and the nearest resistance the Pivot at $6.66.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 22.6%/day
Key levels
$32.5152 week high+409.6%
$23.02200 day average+260.8%
$21.44100 day average+236.1%
$20.50Swing high (Oct 30)+221.3%
$16.5250 day average+158.9%
$10.0020 day average+56.7%
$6.93Pivot R1+8.6%
$6.66Pivot+4.4%
$6.38Last close
$6.10Pivot S1−4.4%
$6.0252 week low−5.6%
Indicators
RSI (14)
23.90
Oversold below 30
Oversold
MACD
-3.06
Above its signal line
Bullish
Stochastic
10.3
Near the bottom of its range
Oversold
ADX (14)
48.2
Strong downtrend
Williams %R
-93.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-95.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−31.8%
Change over 10 sessions
Bearish
ATR (14)
$1.44
Typical daily range, 22.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityNormal, 56.7%/day
Key levels
$32.5152 week high+409.6%
$23.02200 day average+260.8%
$21.44100 day average+236.1%
$20.50Swing high (Oct 30)+221.3%
$16.5250 day average+158.9%
$10.0020 day average+56.7%
$6.93Pivot R1+8.6%
$6.66Pivot+4.4%
$6.38Last close
$6.10Pivot S1−4.4%
$6.0252 week low−5.6%
Indicators
RSI (14)
18.60
Oversold below 30
Oversold
MACD
-4.30
Below its signal line
Bearish
Stochastic
1.3
Near the bottom of its range
Oversold
ADX (14)
34.3
Trending down
Williams %R
-98.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-188.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−70.9%
Change over 10 sessions
Bearish
ATR (14)
$3.62
Typical daily range, 56.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for PTHS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PTHS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PTHSHow many large options trades hit PTHS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PTHS in the last 90 days.
From SEC Form 4 filings by PTHS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTHS is in one of them and how their past PTHS trades turned out.
Pelthos Therapeutics is a biopharmaceutical company based in Durham, North Carolina. It sells prescription skin treatments that have been approved by the U.S. Food and Drug Administration. Its main products are ZELSUVMI, a topical gel for molluscum contagiosum, a common viral skin infection, and XEPI, a cream for impetigo, a bacterial skin infection. The products are used by patients, parents and caregivers, and are prescribed by dermatologists and pediatricians.